Loading company…
Positrigo AG, based in Zurich, develops ultra-compact PET imaging systems, including NeuroLF, for diagnosing neurological disorders.
Founded in 2018 and based in Zurich, Switzerland, Positrigo AG develops and sells ultra-compact Positron Emission Tomography (PET) systems. Its flagship NeuroLF device is used for functional brain imaging, mainly for dementia including Alzheimer's disease, and for epilepsy and neuro-oncology. Revenue comes from direct sales to hospitals, research institutions and clinics, plus maintenance and support. The company has completed five funding rounds totaling CHF 7 million, most recently in June 2025, led by HealthCap with participation from Navivo Capital. CEO Jannis Fischer is among the founders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in